Cargando…
The predictive significance of CD20 expression in B-cell lymphomas
BACKGROUND: In our recent study, we determined the cut-off value of CD20 expression at the level of 25 000 molecules of equivalent soluble fluorochrome (MESF) to be the predictor of response to rituximab containing treatment in patients with B-cell lymphomas. In 17.5% of patients, who had the level...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083324/ https://www.ncbi.nlm.nih.gov/pubmed/21486448 http://dx.doi.org/10.1186/1746-1596-6-33 |